US Senate Recommends Funding For FDA Device Shop In 2020 To Support Cybersecurity, Virtual Trials
Executive Summary
The US Senate Appropriations Committee passed FDA funding levels for 2020 on 19 September that would support medical device cybersecurity and medtech manufacturing, but a continuing resolution measure is waiting in the wings to provide the full Senate more time to consider the measure before the new fiscal year starts on 1 October.
You may also be interested in...
Congress Agrees To Keep FDA, Other Agencies Running At Current Funding Level Through Mid-December
The US Congress this week agreed to keep the FDA and other government agencies funded at fiscal-year 2019 levels, extending the continuing resolution another four weeks until 20 December.
Hahn Fields Queries On Electrical Stim Devices, Molybdenum Supplies For Imaging At FDA Confirmation Hearing
MD Anderson Cancer Center chief medical officer Stephen Hahn fielded a number of questions senators asked at his 20 November confirmation hearing to lead the US FDA. Chief among them were inquiries about his government experience level, whether he would expedite a ban on electrical stimulation devices used against the intellectually disabled, and how he would address a shortage of molybdenum-99 used in advanced imaging scans.
Continuing Resolution Passage Means FDA Funds Stuck At 2019 Levels Through November
The US Senate and House have both approved continuing resolution bills that President Trump is expected to sign shortly to keep the federal government running through 21 November – but that means that the FDA will be stuck at its 2019 funding level until then.